David Wullimann

3.2k total citations
7 papers, 51 citations indexed

About

David Wullimann is a scholar working on Infectious Diseases, Immunology and Genetics. According to data from OpenAlex, David Wullimann has authored 7 papers receiving a total of 51 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 4 papers in Immunology and 2 papers in Genetics. Recurrent topics in David Wullimann's work include SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). David Wullimann is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), COVID-19 Clinical Research Studies (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). David Wullimann collaborates with scholars based in Sweden, Switzerland and United States. David Wullimann's co-authors include Hans‐Gustaf Ljunggren, Marcus Buggert, Soo Aleman, Yu Gao, Fridtjof Lund‐Johansen, Curtis Cai, Mira Akber, Katie Healy, Olga Rivera‐Ballesteros and Smith Rjh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and European Journal of Immunology.

In The Last Decade

David Wullimann

6 papers receiving 51 citations

Peers

David Wullimann
J. Allyson Hays United States
Selina Gierer United States
Yousef Daryani United Kingdom
Patrick Foy United States
David Wullimann
Citations per year, relative to David Wullimann David Wullimann (= 1×) peers Margherita Oberti

Countries citing papers authored by David Wullimann

Since Specialization
Citations

This map shows the geographic impact of David Wullimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wullimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wullimann more than expected).

Fields of papers citing papers by David Wullimann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wullimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wullimann. The network helps show where David Wullimann may publish in the future.

Co-authorship network of co-authors of David Wullimann

This figure shows the co-authorship network connecting the top 25 collaborators of David Wullimann. A scholar is included among the top collaborators of David Wullimann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wullimann. David Wullimann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wullimann, David & Hans‐Gustaf Ljunggren. (2025). Human T Cell Responses to Flavivirus Vaccines. European Journal of Immunology. 55(8). e70027–e70027.
2.
Wullimann, David, John Tyler Sandberg, Mira Akber, et al.. (2025). Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLoS neglected tropical diseases. 19(2). e0012693–e0012693. 3 indexed citations
3.
Andersson, Maria, Jinghua Wu, David Wullimann, et al.. (2023). Local and Systemic Immunity During Five Vaccinations Against SARS-CoV-2 in Zanubrutinib-Treated Patients With Chronic Lymphocytic Leukemia. Journal of Hematology. 12(4). 170–175. 3 indexed citations
4.
Humbert, Marion, David Wullimann, Julia Niessl, et al.. (2023). Functional SARS-CoV-2 cross-reactive CD4 + T cells established in early childhood decline with age. Proceedings of the National Academy of Sciences. 120(12). e2220320120–e2220320120. 15 indexed citations
5.
Bergman, Peter, David Wullimann, Yu Gao, et al.. (2022). Elevated CD21low B Cell Frequency Is a Marker of Poor Immunity to Pfizer-BioNTech BNT162b2 mRNA Vaccine Against SARS-CoV-2 in Patients with Common Variable Immunodeficiency. Journal of Clinical Immunology. 42(4). 716–727. 14 indexed citations
6.
7.
Gao, Yu, David Wullimann, Sandra Muschiol, et al.. (2022). Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination. Blood. 140(22). 2403–2407. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026